Balance Sheet
publishA company’s balance sheet offers vital insights into its financial stability, and the Stocklytics Balance Sheet Screener gives you the tools to analyze stocks based on their key balance sheet metrics. Our screener ranks stocks by descending total assets, allowing you to focus on companies with substantial financial strength.
| name | arrow_downwardASSETS | PRICE | $ CHANGE | % CHANGE | CURRENT ASSETS | CASH ON HAND | LIABILITIES | DEBT | NET DEBT | EQUITY | CURRENT RATIO | QUICK RATIO | DEBT / EQUITY | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBLGBone Biologics | $3.19M | $1.82 | -$0.26 | arrow_drop_down12.50% | $3.19M | $2.33M | $284.50K | $0.00 | -$2.33M | $2.90M | 11.22 | - | 0.00 | AI Analysis | |||
BBLG BBLGWBone Biologics Corporation | $3.19M | $60.50 | $0.00 | 0.00% | $3.19M | $2.33M | $284.50K | $0.00 | -$2.33M | $2.90M | 11.22 | - | 0.00 | AI Analysis | |||
BSGMBioSig Technologies | $3.10M | $0.30 | -$0.01 | arrow_drop_down5.34% | $2.38M | $2.10M | $2.99M | _ | _ | $99.00K | 0.80 | - | 2.43 | AI Analysis | |||
PRFXPainReform Ltd. | $3.10M | $0.75 | -$0.07 | arrow_drop_down9.33% | $2.99M | $2.79M | $5.14M | $59.00K | -$2.73M | -$2.04M | 0.61 | - | - | AI Analysis | |||
ACONAclarion | $3.08M | $0.18 | $0.00 | arrow_drop_up5.11% | $1.77M | $1.18M | $1.44M | $777.08K | -$405.60K | $1.64M | 1.28 | - | 0.47 | AI Analysis | |||
ACONWAclarion | $3.08M | $0.02 | -$0.01 | arrow_drop_down25.25% | $1.77M | $1.18M | $1.44M | $777.08K | -$405.60K | $1.64M | 1.28 | - | 0.47 | AI Analysis | |||
WAVSWestern Acquisition Ventures | $3.07M | $10.43 | $0.02 | arrow_drop_up0.19% | $108.46K | $1,008.00 | $2.89M | $307.97K | $306.96K | $183.81K | 0.03 | - | 0.01 | AI Analysis | |||
CMRAComera Life Sciences Holdings | $3.07M | $0.02 | $0.00 | 0.00% | $2.63M | $1.76M | $7.29M | $561.46K | -$1.59M | -$4.22M | 0.89 | 0.93 | 5.49 | AI Analysis | |||
MGAMMobile Global Esports | $3.03M | $0.01 | $0.00 | arrow_drop_up6.25% | $2.89M | $2.76M | $510.80K | $181.16K | -$2.65M | $2.53M | 6.10 | - | 0.07 | AI Analysis | |||
YTENYield10 Bioscience | $2.96M | $1.15 | $0.00 | 0.00% | $1.20M | $733.00K | $9.20M | $2.75M | $2.05M | -$6.23M | 0.15 | - | - | AI Analysis | |||
PXMDPaxMedica | $2.89M | $0.08 | -$0.00 | arrow_drop_down9.37% | $2.89M | $1.62M | $1.70M | $0.00 | -$1.62M | $1.19M | 2.40 | - | 0.00 | AI Analysis | |||
BCDABioCardia | $2.89M | $2.98 | -$0.10 | arrow_drop_down3.24% | $1.57M | $1.42M | $4.85M | $1.13M | -$283.00K | -$1.96M | 0.38 | - | - | AI Analysis | |||
PETV PETVWPetVivo Holdings | $2.88M | $0.02 | $0.00 | arrow_drop_up3.63% | $880.06K | $12.41K | $2.05M | $1.16M | $1.15M | $829.50K | 0.80 | 0.45 | 1.40 | AI Analysis | |||
PETVPetVivo Holdings | $2.88M | $0.54 | $0.00 | arrow_drop_up0.92% | $880.06K | $12.41K | $2.05M | $1.16M | $1.15M | $829.50K | 0.80 | 0.45 | 1.40 | AI Analysis | |||
OPGNOpGen | $2.86M | $2.02 | $0.02 | arrow_drop_up1.00% | $572.77K | $168.11K | $14.53M | $13.19M | _ | -$11.66M | 0.04 | 0.04 | - | AI Analysis | |||
SHPHShuttle Pharmaceuticals Holdings | $2.81M | $1.62 | -$0.04 | arrow_drop_down2.40% | $2.48M | $695.59K | $2.01M | $1.15M | $459.75K | $801.43K | 1.79 | 1.79 | 1.44 | AI Analysis | |||
MGOLMGO Global Inc. Common Stock | $2.80M | $2.77 | $0.12 | arrow_drop_up4.52% | $2.53M | $1.30M | $837.74K | $49.03K | -$1.25M | $2.33M | 3.03 | 2.02 | 0.02 | AI Analysis | |||
ENSCEnsysce Biosciences | $2.79M | $0.33 | $0.00 | arrow_drop_up0.09% | $2.45M | $1.04M | $1.31M | $454.46K | -$595.07K | $1.80M | 1.88 | 2.05 | 0.30 | AI Analysis | |||
NUZENuZee | $2.74M | $0.69 | -$0.33 | arrow_drop_down32.81% | $1.92M | $374.45K | $2.94M | $322.69K | -$51.76K | -$193.61K | 0.70 | 0.36 | - | AI Analysis | |||
KNWKnow Labs | $2.74M | $0.28 | $0.00 | 0.00% | $2.12M | $2.12M | $7.34M | $5.87M | $3.74M | -$4.60M | 0.34 | - | - | AI Analysis |
Showing 4861-4880 of 4977
Results per page:
A company’s balance sheet offers vital insights into its financial stability, and the Stocklytics Balance Sheet Screener gives you the tools to analyze stocks based on their key balance sheet metrics. Our screener ranks stocks by descending total assets, allowing you to focus on companies with substantial financial strength.
In addition to total assets, the screener provides critical balance sheet details:
- Current Assets – View a company’s liquid assets and those expected to be converted into cash within a year.
- Cash on Hand – Evaluate a company’s cash reserves, a key indicator of liquidity and financial flexibility.
- Liabilities – Examine both short-term and long-term obligations, providing insights into a company’s financial commitments.
- Debt – Get a breakdown of a company’s debt levels, including the impact of borrowing on its financial structure.
- Net Debt – See the company’s total debt minus its cash on hand for a clearer picture of its actual debt burden.
- Equity – Review the value of shareholder equity to understand the company’s financial foundation.
- Current Ratio – Measure a company’s ability to cover short-term obligations with its current assets.
- Quick Ratio – Analyze a company’s liquidity by excluding inventory from current assets, focusing on more readily available resources.
- Debt/Equity Ratio – Assess how leveraged a company is by comparing its total debt to shareholder equity.
- The Stocklytics Balance Sheet Screener gives you all the data needed to evaluate a company's financial health at a glance, allowing you to focus on metrics that matter most for assessing long-term stability.
Why Use the Balance Sheet Screener?
- Financial Strength: Identify companies with strong balance sheets, essential for long-term investment.
- Liquidity: Focus on firms with high liquidity ratios for safer investments.
- Leverage: Understand a company's debt load and its impact on future profitability.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools